Investor Webinar Presentation
Filed with ASX · · 23 pages · English and French
Summary by 6ix AI
Proteomics International Laboratories Ltd. has released an investor webinar presentation outlining its commercial strategy and growth plans. The company has secured a distribution partnership with Healius and is rolling out its Promarker tests nationally in Australia. A share purchase plan is being launched to raise funds for further commercial execution and market access, targeting operations through the following year. The presentation emphasizes the potential market for its diagnostic tests and outlines a strategic roadmap for the next three years.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
This presentation has been prepared by, and is the sole responsibility of Proteomics International Laboratories Ltd (Proteomics International, Proteomics, the Company, ASX: PIQ) and is dated 4 November 2026. The Company is under no obligation to update or keep the information represented in this presentation current past the date of presenting. All information is subject to change without notice.
Proteomics International Laboratories Ltd. on 6ix
Earlier from Proteomics International Laboratories
- Security Purchase Plan Offer Booklet
- Share Purchase Plan Cleansing Notice
- Proteomics International Launches Share Purchase Plan
- Quarterly Activities/Appendix 4C Cash Flow Report
- National Rollout of PromarkerD and PromarkerEso
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories